LAMEA Molecular Diagnostics Market (2016 - 2022)
Molecular Diagnostics is used to identify or monitor biomarkers associated with any particular diseases or conditions. This test could also help in detecting and quantifying the presence of specific bacteria and viruses. These devices help surgeons in deciding that which therapy would work best on different patients. Molecular Diagnostics detect the diseases by analyzing RNA (Ribonucleic Acid) or DNA (Deoxyribonucleic Acid) in humans. These diagnostics are mainly used for clinical testing devices that are supplied in clinics, hospitals, laboratories, and research institutes.
Rise in the incidence of chronic & infectious diseases and technological advancements is leading the market for molecular diagnostics market in LAMEA. According to the report by Avert in 2016, In Latin America, 1.6 people and In Brazil 830,000 peoples are dealing with HIV. Considering Middle East, studies stated that Middle East is a region with highest number of breast cancer cases and diseases. And the most effected population is the women under 60. In Addition, doctors have also stated the people are still unaware about the health issues in U.A.E and it is leading towards increase in infectious diseases.
The Molecular Diagnostics Market is segmented on the basis of Product & Services, Technology, Application, End-user and Region. Based on Product & Services, the market is segmented into instruments, reagents & Kits, and software & services. Reagents & Kits is expected to gather largest share in the market due to rising demand of reagents in clinical centers and diagnostics centers. Based on Technology, market is segmented into Polymerase Chain Reaction (PCR), Microarray, Isothermal Nucleic Acid Amplification Technology (INAAT), Hybridization, Microarray, DNA Sequencing and Next-Generation Sequencing.
The Molecular Diagnostics Market is segmented on the basis of Product & Services, Technology, Application, End-user and Region. Based on Product & Services, the market is segmented into instruments, reagents & Kits, and software & services. Reagents & Kits is expected to gather largest share in the market due to rising demand of reagents in clinical centers and diagnostics centers. Based on Technology, market is segmented into Polymerase Chain Reaction (PCR), Microarray, Isothermal Nucleic Acid Amplification Technology (INAAT), Hybridization, Microarray, DNA Sequencing and Next-Generation Sequencing.
Based on Application, the market is segmented into six types such as Infectious diseases molecular testing, Molecular oncology testing, Inherited diseases molecular testing, Identity testing, Tissue type testing and Pharmacogenetics testing. Infectious Diseases includes Chlamydia Trachomatis and Neisseria Gonorrhoeae (CT/NG), Human Papillomavirus (HPV), Human Immunodeficiency Virus (HIV), Tuberculosis (TB), Hepatitis B, Hepatitis C, Tuberculosis (TB), Methicillin-Resistant Staphylococcus Aureus (MRSA) and other infectious diseases. On the other hand, oncology is further divided into Breast Cancer, Prostate Cancer, Colorectal Cancer and others. The infectious diseases molecular testing is mostly preferred in the hospitals and clinical centers. Based on End-User, the market is segmented into i clinics, hospitals, laboratories, and research institutes. Based on Country, market is segmented into Brazil, Argentina, UAE, Saudia Arabia, South Africa, Nigeria and Rest of LAMEA.
The report covers the analysis of key stake holders of the Molecular Diagnostics market. Key companies profiled in the report include Abbott Laboratories, Qiagen N.V, Roche Diagnostics, Grifols, Siemens Healthcare (Siemens AG), Becton Dickinson and Company and Danaher Corporation.
Rise in the incidence of chronic & infectious diseases and technological advancements is leading the market for molecular diagnostics market in LAMEA. According to the report by Avert in 2016, In Latin America, 1.6 people and In Brazil 830,000 peoples are dealing with HIV. Considering Middle East, studies stated that Middle East is a region with highest number of breast cancer cases and diseases. And the most effected population is the women under 60. In Addition, doctors have also stated the people are still unaware about the health issues in U.A.E and it is leading towards increase in infectious diseases.
The Molecular Diagnostics Market is segmented on the basis of Product & Services, Technology, Application, End-user and Region. Based on Product & Services, the market is segmented into instruments, reagents & Kits, and software & services. Reagents & Kits is expected to gather largest share in the market due to rising demand of reagents in clinical centers and diagnostics centers. Based on Technology, market is segmented into Polymerase Chain Reaction (PCR), Microarray, Isothermal Nucleic Acid Amplification Technology (INAAT), Hybridization, Microarray, DNA Sequencing and Next-Generation Sequencing.
The Molecular Diagnostics Market is segmented on the basis of Product & Services, Technology, Application, End-user and Region. Based on Product & Services, the market is segmented into instruments, reagents & Kits, and software & services. Reagents & Kits is expected to gather largest share in the market due to rising demand of reagents in clinical centers and diagnostics centers. Based on Technology, market is segmented into Polymerase Chain Reaction (PCR), Microarray, Isothermal Nucleic Acid Amplification Technology (INAAT), Hybridization, Microarray, DNA Sequencing and Next-Generation Sequencing.
Based on Application, the market is segmented into six types such as Infectious diseases molecular testing, Molecular oncology testing, Inherited diseases molecular testing, Identity testing, Tissue type testing and Pharmacogenetics testing. Infectious Diseases includes Chlamydia Trachomatis and Neisseria Gonorrhoeae (CT/NG), Human Papillomavirus (HPV), Human Immunodeficiency Virus (HIV), Tuberculosis (TB), Hepatitis B, Hepatitis C, Tuberculosis (TB), Methicillin-Resistant Staphylococcus Aureus (MRSA) and other infectious diseases. On the other hand, oncology is further divided into Breast Cancer, Prostate Cancer, Colorectal Cancer and others. The infectious diseases molecular testing is mostly preferred in the hospitals and clinical centers. Based on End-User, the market is segmented into i clinics, hospitals, laboratories, and research institutes. Based on Country, market is segmented into Brazil, Argentina, UAE, Saudia Arabia, South Africa, Nigeria and Rest of LAMEA.
The report covers the analysis of key stake holders of the Molecular Diagnostics market. Key companies profiled in the report include Abbott Laboratories, Qiagen N.V, Roche Diagnostics, Grifols, Siemens Healthcare (Siemens AG), Becton Dickinson and Company and Danaher Corporation.
CHAPTER 1. MARKET SCOPE & METHODOLOGY
1.1 Market Definition
1.2 Objectives
1.3 Market Scope
1.4 Segmentation
1.4.1 LAMEA Molecular Diagnostics Market, by Product & Services
1.4.2 LAMEA Molecular Diagnostics Market, by Technology
1.4.3 LAMEA Molecular Diagnostics Market, by Application
1.4.4 LAMEA Molecular Diagnostics Market, by End User
1.4.5 LAMEA Molecular Diagnostics Market, by Country
1.5 Methodology for the research
CHAPTER 2. EXECUTIVE SUMMARY
CHAPTER 3. MARKET OVERVIEW
3.1 Introduction
3.2 Drivers, Restraints and Opportunities
3.2.1 Market Drivers
3.2.2 Market Restraints
CHAPTER 4. LAMEA MOLECULAR DIAGNOSTICS MARKET
4.1 LAMEA Molecular Diagnostics Market by Product & Services
4.1.1 LAMEA Molecular Diagnostics Reagents & Kits Market by Country
4.1.2 LAMEA Molecular Diagnostics Instruments Market by Country
4.1.3 LAMEA Molecular Diagnostics Software & Services Market by Country
CHAPTER 5. LAMEA MOLECULAR DIAGNOSTICS MARKET BY TECHNOLOGY
5.1 Introduction
5.1.1 LAMEA Polymerase Chain Reaction Molecular Diagnostics Market by Country
5.1.2 LAMEA Isothermal Nucleic Acid Amplification Technology Molecular Diagnostics Market by Country
5.1.3 LAMEA Hybridization Molecular Diagnostics Market by Country
5.1.4 LAMEA DNA Sequencing & Next-Generation Sequencing Molecular Diagnostics Market by Country
5.1.5 LAMEA Microarray Molecular Diagnostics Market by Country
5.1.6 LAMEA Other Technologies Market by Country
CHAPTER 6. LAMEA MOLECULAR DIAGNOSTICS MARKET BY APPLICATION
6.1 Introduction
6.1.1 LAMEA Infectious Diseases Molecular Diagnostics Market by Country
6.1.2 LAMEA Infectious Diseases Molecular Diagnostics Market by Type
6.1.2.1 LAMEA Chlamydia Trachomatis & Neisseria Gonorrhea Molecular Diagnostics Market by Country
6.1.2.2 LAMEA Hepatitis B & Hepatitis C Molecular Diagnostics Market by Country
6.1.2.3 LAMEA Human Papillomavirus Molecular Diagnostics Market by Country
6.1.2.4 LAMEA Human Immunodeficiency Virus Molecular Diagnostics Market by Country
6.1.2.5 LAMEA Tuberculosis Molecular Diagnostics Market by Country
6.1.2.6 LAMEA Methicillin-Resistant Staphylococcus Aurous Molecular Diagnostics Market by Country
6.1.2.7 LAMEA Molecular Diagnostics in Other Infectious Diseases Market by Country
6.1.3 LAMEA Oncology Molecular Diagnostics Market by Country
6.1.4 LAMEA Oncology Molecular Diagnostics Market by Type
6.1.4.1 LAMEA Breast Cancer Molecular Diagnostics Market by Country
6.1.4.2 LAMEA Colorectal Cancer Molecular Diagnostics Market by Country
6.1.4.3 LAMEA Prostate Cancer Molecular Diagnostics Market by Country
6.1.4.4 LAMEA Other Cancers Molecular Diagnostics Market by Country
6.1.5 LAMEA Blood Screening Molecular Diagnostics Market by Country
6.1.6 LAMEA Genetic Tests Molecular Diagnostics Market by Country
6.1.7 LAMEA Microbiology Molecular Diagnostics Market by Country
6.1.8 LAMEA Other Applications Market by Country
CHAPTER 7. LAMEA MOLECULAR DIAGNOSTICS MARKET BY END USER
7.1 Introduction
7.1.1 LAMEA Molecular Diagnostics Market for Hospital & Academic Laboratories by Country
7.1.2 LAMEA Molecular Diagnostics Market for Reference Laboratories by Country
7.1.3 LAMEA Molecular Diagnostics Market for Other End Users by Country
CHAPTER 8. LAMEA MOLECULAR DIAGNOSTICS MARKET BY COUNTRY
8.1 Introduction
8.2 Brazil Molecular Diagnostics Market
8.2.1 Brazil Molecular Diagnostics Market by Product & Services
8.2.2 Brazil Molecular Diagnostics Market by Technology
8.2.3 Brazil Molecular Diagnostics Market by Application
8.2.3.1 Brazil Infectious Diseases Molecular Diagnostics Market by Type
8.2.3.2 Brazil Oncology Molecular Diagnostics Market by Type
8.2.4 Brazil Molecular Diagnostics Market by End User
8.3 Argentina Molecular Diagnostics Market
8.3.1 Argentina Molecular Diagnostics Market by Product & Services
8.3.2 Argentina Molecular Diagnostics Market by Technology
8.3.3 Argentina Molecular Diagnostics Market by Application
8.3.3.1 Argentina Infectious Diseases Molecular Diagnostics Market by Type
8.3.3.2 Argentina Oncology Molecular Diagnostics Market by Type
8.3.4 Argentina Molecular Diagnostics Market by End User
8.4 UAE Molecular Diagnostics Market
8.4.1 UAE Molecular Diagnostics Market by Product & Services
8.4.2 UAE Molecular Diagnostics Market by Technology
8.4.3 UAE Molecular Diagnostics Market by Application
8.4.3.1 UAE Infectious Diseases Molecular Diagnostics Market by Type
8.4.3.2 UAE Oncology Molecular Diagnostics Market by Type
8.4.4 UAE Molecular Diagnostics Market by End User
8.5 Saudi Arabia Molecular Diagnostics Market
8.5.1 Saudi Arabia Molecular Diagnostics Market by Product & Services
8.5.2 Saudi Arabia Molecular Diagnostics Market by Technology
8.5.3 Saudi Arabia Molecular Diagnostics Market by Application
8.5.3.1 Saudi Arabia Infectious Diseases Molecular Diagnostics Market by Type
8.5.3.2 Saudi Arabia Oncology Molecular Diagnostics Market by Type
8.5.4 Saudi Arabia Molecular Diagnostics Market by End User
8.6 South Africa Molecular Diagnostics Market
8.6.1 South Africa Molecular Diagnostics Market by Product & Services
8.6.2 South Africa Molecular Diagnostics Market by Technology
8.6.3 South Africa Molecular Diagnostics Market by Application
8.6.3.1 South Africa Infectious Diseases Molecular Diagnostics Market by Type
8.6.3.2 South Africa Oncology Molecular Diagnostics Market by Type
8.6.4 South Africa Molecular Diagnostics Market by End User
8.7 Nigeria Molecular Diagnostics Market
8.7.1 Nigeria Molecular Diagnostics Market by Product & Services
8.7.2 Nigeria Molecular Diagnostics Market by Technology
8.7.3 Nigeria Molecular Diagnostics Market by Application
8.7.3.1 Nigeria Infectious Diseases Molecular Diagnostics Market by Type
8.7.3.2 Nigeria Oncology Molecular Diagnostics Market by Type
8.7.4 Nigeria Molecular Diagnostics Market by End User
8.8 Rest of LAMEA Molecular Diagnostics Market
8.8.1 Rest of LAMEA Molecular Diagnostics Market by Product & Services
8.8.2 Rest of LAMEA Molecular Diagnostics Market by Technology
8.8.3 Rest of LAMEA Molecular Diagnostics Market by Application
8.8.3.1 Rest of LAMEA Infectious Diseases Molecular Diagnostics Market by Type
8.8.3.2 Rest of LAMEA Oncology Molecular Diagnostics Market by Type
8.8.3.3 Rest of LAMEA Molecular Diagnostics Market by End User
CHAPTER 9. COMPANY PROFILES
9.1 Abbott Laboratories
9.1.1 Company Overview
9.1.2 Financial Analysis
9.1.3 Segmental and Regional Analysis
9.1.4 Research & Development Expense
9.2 Qiagen N.V.
9.2.1 Company Overview
9.2.2 Financial Analysis
9.2.3 Segmental and Regional Analysis
9.2.4 Research & Development Expense
9.3 Roche Diagnostics
9.3.1 Company Overview
9.3.2 Financial Analysis
9.3.3 Segmental and Regional Analysis
9.3.4 Research & Development Expense
9.4 Grifols
9.4.1 Company Overview
9.4.2 Financial Analysis
9.4.3 Segmental and Regional Analysis
9.5 Siemens Healthcare (Siemens AG)
9.5.1 Company Overview
9.5.2 Financial Analysis
9.5.3 Segmental and Regional Analysis
9.5.4 Research & Development Expense
9.6 Becton Dickinson and Company
9.6.1 Company Overview
9.6.2 Financial Analysis
9.6.3 Segmental and Regional Analysis
9.6.4 Research & Development Expense
9.7 Danaher Corporation
9.7.1 Company Overview
9.7.2 Financial Analysis
9.7.3 Segmental and Regional Analysis
9.7.4 Research & Development Expense
1.1 Market Definition
1.2 Objectives
1.3 Market Scope
1.4 Segmentation
1.4.1 LAMEA Molecular Diagnostics Market, by Product & Services
1.4.2 LAMEA Molecular Diagnostics Market, by Technology
1.4.3 LAMEA Molecular Diagnostics Market, by Application
1.4.4 LAMEA Molecular Diagnostics Market, by End User
1.4.5 LAMEA Molecular Diagnostics Market, by Country
1.5 Methodology for the research
CHAPTER 2. EXECUTIVE SUMMARY
CHAPTER 3. MARKET OVERVIEW
3.1 Introduction
3.2 Drivers, Restraints and Opportunities
3.2.1 Market Drivers
3.2.2 Market Restraints
CHAPTER 4. LAMEA MOLECULAR DIAGNOSTICS MARKET
4.1 LAMEA Molecular Diagnostics Market by Product & Services
4.1.1 LAMEA Molecular Diagnostics Reagents & Kits Market by Country
4.1.2 LAMEA Molecular Diagnostics Instruments Market by Country
4.1.3 LAMEA Molecular Diagnostics Software & Services Market by Country
CHAPTER 5. LAMEA MOLECULAR DIAGNOSTICS MARKET BY TECHNOLOGY
5.1 Introduction
5.1.1 LAMEA Polymerase Chain Reaction Molecular Diagnostics Market by Country
5.1.2 LAMEA Isothermal Nucleic Acid Amplification Technology Molecular Diagnostics Market by Country
5.1.3 LAMEA Hybridization Molecular Diagnostics Market by Country
5.1.4 LAMEA DNA Sequencing & Next-Generation Sequencing Molecular Diagnostics Market by Country
5.1.5 LAMEA Microarray Molecular Diagnostics Market by Country
5.1.6 LAMEA Other Technologies Market by Country
CHAPTER 6. LAMEA MOLECULAR DIAGNOSTICS MARKET BY APPLICATION
6.1 Introduction
6.1.1 LAMEA Infectious Diseases Molecular Diagnostics Market by Country
6.1.2 LAMEA Infectious Diseases Molecular Diagnostics Market by Type
6.1.2.1 LAMEA Chlamydia Trachomatis & Neisseria Gonorrhea Molecular Diagnostics Market by Country
6.1.2.2 LAMEA Hepatitis B & Hepatitis C Molecular Diagnostics Market by Country
6.1.2.3 LAMEA Human Papillomavirus Molecular Diagnostics Market by Country
6.1.2.4 LAMEA Human Immunodeficiency Virus Molecular Diagnostics Market by Country
6.1.2.5 LAMEA Tuberculosis Molecular Diagnostics Market by Country
6.1.2.6 LAMEA Methicillin-Resistant Staphylococcus Aurous Molecular Diagnostics Market by Country
6.1.2.7 LAMEA Molecular Diagnostics in Other Infectious Diseases Market by Country
6.1.3 LAMEA Oncology Molecular Diagnostics Market by Country
6.1.4 LAMEA Oncology Molecular Diagnostics Market by Type
6.1.4.1 LAMEA Breast Cancer Molecular Diagnostics Market by Country
6.1.4.2 LAMEA Colorectal Cancer Molecular Diagnostics Market by Country
6.1.4.3 LAMEA Prostate Cancer Molecular Diagnostics Market by Country
6.1.4.4 LAMEA Other Cancers Molecular Diagnostics Market by Country
6.1.5 LAMEA Blood Screening Molecular Diagnostics Market by Country
6.1.6 LAMEA Genetic Tests Molecular Diagnostics Market by Country
6.1.7 LAMEA Microbiology Molecular Diagnostics Market by Country
6.1.8 LAMEA Other Applications Market by Country
CHAPTER 7. LAMEA MOLECULAR DIAGNOSTICS MARKET BY END USER
7.1 Introduction
7.1.1 LAMEA Molecular Diagnostics Market for Hospital & Academic Laboratories by Country
7.1.2 LAMEA Molecular Diagnostics Market for Reference Laboratories by Country
7.1.3 LAMEA Molecular Diagnostics Market for Other End Users by Country
CHAPTER 8. LAMEA MOLECULAR DIAGNOSTICS MARKET BY COUNTRY
8.1 Introduction
8.2 Brazil Molecular Diagnostics Market
8.2.1 Brazil Molecular Diagnostics Market by Product & Services
8.2.2 Brazil Molecular Diagnostics Market by Technology
8.2.3 Brazil Molecular Diagnostics Market by Application
8.2.3.1 Brazil Infectious Diseases Molecular Diagnostics Market by Type
8.2.3.2 Brazil Oncology Molecular Diagnostics Market by Type
8.2.4 Brazil Molecular Diagnostics Market by End User
8.3 Argentina Molecular Diagnostics Market
8.3.1 Argentina Molecular Diagnostics Market by Product & Services
8.3.2 Argentina Molecular Diagnostics Market by Technology
8.3.3 Argentina Molecular Diagnostics Market by Application
8.3.3.1 Argentina Infectious Diseases Molecular Diagnostics Market by Type
8.3.3.2 Argentina Oncology Molecular Diagnostics Market by Type
8.3.4 Argentina Molecular Diagnostics Market by End User
8.4 UAE Molecular Diagnostics Market
8.4.1 UAE Molecular Diagnostics Market by Product & Services
8.4.2 UAE Molecular Diagnostics Market by Technology
8.4.3 UAE Molecular Diagnostics Market by Application
8.4.3.1 UAE Infectious Diseases Molecular Diagnostics Market by Type
8.4.3.2 UAE Oncology Molecular Diagnostics Market by Type
8.4.4 UAE Molecular Diagnostics Market by End User
8.5 Saudi Arabia Molecular Diagnostics Market
8.5.1 Saudi Arabia Molecular Diagnostics Market by Product & Services
8.5.2 Saudi Arabia Molecular Diagnostics Market by Technology
8.5.3 Saudi Arabia Molecular Diagnostics Market by Application
8.5.3.1 Saudi Arabia Infectious Diseases Molecular Diagnostics Market by Type
8.5.3.2 Saudi Arabia Oncology Molecular Diagnostics Market by Type
8.5.4 Saudi Arabia Molecular Diagnostics Market by End User
8.6 South Africa Molecular Diagnostics Market
8.6.1 South Africa Molecular Diagnostics Market by Product & Services
8.6.2 South Africa Molecular Diagnostics Market by Technology
8.6.3 South Africa Molecular Diagnostics Market by Application
8.6.3.1 South Africa Infectious Diseases Molecular Diagnostics Market by Type
8.6.3.2 South Africa Oncology Molecular Diagnostics Market by Type
8.6.4 South Africa Molecular Diagnostics Market by End User
8.7 Nigeria Molecular Diagnostics Market
8.7.1 Nigeria Molecular Diagnostics Market by Product & Services
8.7.2 Nigeria Molecular Diagnostics Market by Technology
8.7.3 Nigeria Molecular Diagnostics Market by Application
8.7.3.1 Nigeria Infectious Diseases Molecular Diagnostics Market by Type
8.7.3.2 Nigeria Oncology Molecular Diagnostics Market by Type
8.7.4 Nigeria Molecular Diagnostics Market by End User
8.8 Rest of LAMEA Molecular Diagnostics Market
8.8.1 Rest of LAMEA Molecular Diagnostics Market by Product & Services
8.8.2 Rest of LAMEA Molecular Diagnostics Market by Technology
8.8.3 Rest of LAMEA Molecular Diagnostics Market by Application
8.8.3.1 Rest of LAMEA Infectious Diseases Molecular Diagnostics Market by Type
8.8.3.2 Rest of LAMEA Oncology Molecular Diagnostics Market by Type
8.8.3.3 Rest of LAMEA Molecular Diagnostics Market by End User
CHAPTER 9. COMPANY PROFILES
9.1 Abbott Laboratories
9.1.1 Company Overview
9.1.2 Financial Analysis
9.1.3 Segmental and Regional Analysis
9.1.4 Research & Development Expense
9.2 Qiagen N.V.
9.2.1 Company Overview
9.2.2 Financial Analysis
9.2.3 Segmental and Regional Analysis
9.2.4 Research & Development Expense
9.3 Roche Diagnostics
9.3.1 Company Overview
9.3.2 Financial Analysis
9.3.3 Segmental and Regional Analysis
9.3.4 Research & Development Expense
9.4 Grifols
9.4.1 Company Overview
9.4.2 Financial Analysis
9.4.3 Segmental and Regional Analysis
9.5 Siemens Healthcare (Siemens AG)
9.5.1 Company Overview
9.5.2 Financial Analysis
9.5.3 Segmental and Regional Analysis
9.5.4 Research & Development Expense
9.6 Becton Dickinson and Company
9.6.1 Company Overview
9.6.2 Financial Analysis
9.6.3 Segmental and Regional Analysis
9.6.4 Research & Development Expense
9.7 Danaher Corporation
9.7.1 Company Overview
9.7.2 Financial Analysis
9.7.3 Segmental and Regional Analysis
9.7.4 Research & Development Expense
LIST OF TABLES
TABLE 1 LAMEA MOLECULAR DIAGNOSTICS MARKET, 2012 - 2015, USD MILLION
TABLE 2 LAMEA MOLECULAR DIAGNOSTICS MARKET, 2016 - 2022, USD MILLION
TABLE 3 LAMEA MOLECULAR DIAGNOSTICS MARKET BY PRODUCT & SERVICES, 2012 - 2015, USD MILLION
TABLE 4 LAMEA MOLECULAR DIAGNOSTICS MARKET BY PRODUCT & SERVICES, 2016 - 2022, USD MILLION
TABLE 5 LAMEA MOLECULAR DIAGNOSTICS REAGENTS & KITS MARKET BY COUNTRY, 2012 - 2015, USD MILLION
TABLE 6 LAMEA MOLECULAR DIAGNOSTICS REAGENTS & KITS MARKET BY COUNTRY, 2016 - 2022, USD MILLION
TABLE 7 LAMEA MOLECULAR DIAGNOSTICS INSTRUMENTS MARKET BY COUNTRY, 2012 - 2015, USD MILLION
TABLE 8 LAMEA MOLECULAR DIAGNOSTICS INSTRUMENTS MARKET BY COUNTRY, 2016 - 2022, USD MILLION
TABLE 9 LAMEA MOLECULAR DIAGNOSTICS SOFTWARE & SERVICES MARKET BY COUNTRY, 2012 - 2015, USD MILLION
TABLE 10 LAMEA MOLECULAR DIAGNOSTICS SOFTWARE & SERVICES MARKET BY COUNTRY, 2016 - 2022, USD MILLION
TABLE 11 LAMEA MOLECULAR DIAGNOSTICS MARKET BY TECHNOLOGY, 2012 - 2015, USD MILLION
TABLE 12 LAMEA MOLECULAR DIAGNOSTICS MARKET BY TECHNOLOGY, 2016 - 2022, USD MILLION
TABLE 13 LAMEA POLYMERASE CHAIN REACTION MOLECULAR DIAGNOSTICS MARKET BY COUNTRY, 2012 - 2015, USD MILLION
TABLE 14 LAMEA POLYMERASE CHAIN REACTION MOLECULAR DIAGNOSTICS MARKET BY COUNTRY, 2016 - 2022, USD MILLION
TABLE 15 LAMEA ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MOLECULAR DIAGNOSTICS MARKET BY COUNTRY, 2012 - 2015, USD MILLION
TABLE 16 LAMEA ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MOLECULAR DIAGNOSTICS MARKET BY COUNTRY, 2016 - 2022, USD MILLION
TABLE 17 LAMEA HYBRIDIZATION MOLECULAR DIAGNOSTICS MARKET BY COUNTRY, 2012 - 2015, USD MILLION
TABLE 18 LAMEA HYBRIDIZATION MOLECULAR DIAGNOSTICS MARKET BY COUNTRY, 2016 - 2022, USD MILLION
TABLE 19 LAMEA DNA SEQUENCING & NEXT-GENERATION SEQUENCING MOLECULAR DIAGNOSTICS MARKET BY COUNTRY, 2012 - 2015, USD MILLION
TABLE 20 LAMEA DNA SEQUENCING & NEXT-GENERATION SEQUENCING MOLECULAR DIAGNOSTICS MARKET BY COUNTRY, 2016 - 2022, USD MILLION
TABLE 21 LAMEA MICROARRAY MOLECULAR DIAGNOSTICS MARKET BY COUNTRY, 2012 - 2015, USD MILLION
TABLE 22 LAMEA MICROARRAY MOLECULAR DIAGNOSTICS MARKET BY COUNTRY, 2016 - 2022, USD MILLION
TABLE 23 LAMEA OTHER TECHNOLOGIES MARKET BY COUNTRY, 2012 - 2015, USD MILLION
TABLE 24 LAMEA OTHER TECHNOLOGIES MARKET BY COUNTRY, 2016 - 2022, USD MILLION
TABLE 25 LAMEA MOLECULAR DIAGNOSTICS MARKET BY APPLICATION 2012 - 2015, USD MILLION
TABLE 26 LAMEA MOLECULAR DIAGNOSTICS MARKET BY APPLICATION 2016 - 2022, USD MILLION
TABLE 27 LAMEA INFECTIOUS DISEASES MOLECULAR DIAGNOSTICS MARKET BY COUNTRY, 2012 - 2015, USD MILLION
TABLE 28 LAMEA INFECTIOUS DISEASES MOLECULAR DIAGNOSTICS MARKET BY COUNTRY, 2016 - 2022, USD MILLION
TABLE 29 LAMEA INFECTIOUS DISEASES MOLECULAR DIAGNOSTICS MARKET BY TYPE, 2012 - 2015, USD MILLION
TABLE 30 LAMEA INFECTIOUS DISEASES MOLECULAR DIAGNOSTICS MARKET BY TYPE, 2016 - 2022, USD MILLION
TABLE 31 LAMEA CHLAMYDIA TRACHOMATIS & NEISSERIA GONORRHEA MOLECULAR DIAGNOSTICS MARKET BY COUNTRY, 2012 - 2015, USD MILLION
TABLE 32 LAMEA CHLAMYDIA TRACHOMATIS & NEISSERIA GONORRHEA MOLECULAR DIAGNOSTICS MARKET BY COUNTRY, 2016 - 2022, USD MILLION
TABLE 33 LAMEA HEPATITIS B & HEPATITIS C MOLECULAR DIAGNOSTICS MARKET BY COUNTRY, 2012 - 2015, USD MILLION
TABLE 34 LAMEA HEPATITIS B & HEPATITIS C MOLECULAR DIAGNOSTICS MARKET BY COUNTRY, 2016 - 2022, USD MILLION
TABLE 35 LAMEA HUMAN PAPILLOMAVIRUS MOLECULAR DIAGNOSTICS MARKET BY COUNTRY, 2012 - 2015, USD MILLION
TABLE 36 LAMEA HUMAN PAPILLOMAVIRUS MOLECULAR DIAGNOSTICS MARKET BY COUNTRY, 2016 - 2022, USD MILLION
TABLE 37 LAMEA HUMAN IMMUNODEFICIENCY VIRUS MOLECULAR DIAGNOSTICS MARKET BY COUNTRY, 2012 - 2015, USD MILLION
TABLE 38 LAMEA HUMAN IMMUNODEFICIENCY VIRUS MOLECULAR DIAGNOSTICS MARKET BY COUNTRY, 2016 - 2022, USD MILLION
TABLE 39 LAMEA TUBERCULOSIS MOLECULAR DIAGNOSTICS MARKET BY COUNTRY, 2012 - 2015, USD MILLION
TABLE 40 LAMEA TUBERCULOSIS MOLECULAR DIAGNOSTICS MARKET BY COUNTRY, 2016 - 2022, USD MILLION
TABLE 41 LAMEA METHICILLIN-RESISTANT STAPHYLOCOCCUS AUROUS MOLECULAR DIAGNOSTICS MARKET BY COUNTRY, 2012 - 2015, USD MILLION
TABLE 42 LAMEA METHICILLIN-RESISTANT STAPHYLOCOCCUS AUROUS MOLECULAR DIAGNOSTICS MARKET BY COUNTRY, 2016 - 2022, USD MILLION
TABLE 43 LAMEA MOLECULAR DIAGNOSTICS IN OTHER INFECTIOUS DISEASES MARKET BY COUNTRY, 2012 - 2015, USD MILLION
TABLE 44 LAMEA MOLECULAR DIAGNOSTICS IN OTHER INFECTIOUS DISEASES MARKET BY COUNTRY, 2016 - 2022, USD MILLION
TABLE 45 LAMEA ONCOLOGY MOLECULAR DIAGNOSTICS MARKET BY COUNTRY, 2012 - 2015, USD MILLION
TABLE 46 LAMEA ONCOLOGY MOLECULAR DIAGNOSTICS MARKET BY COUNTRY, 2016 - 2022, USD MILLION
TABLE 47 LAMEA ONCOLOGY MOLECULAR DIAGNOSTICS MARKET BY TYPE, 2012 - 2015, USD MILLION
TABLE 48 LAMEA ONCOLOGY MOLECULAR DIAGNOSTICS MARKET BY TYPE, 2016 - 2022, USD MILLION
TABLE 49 LAMEA BREAST CANCER MOLECULAR DIAGNOSTICS MARKET BY COUNTRY, 2012 - 2015, USD MILLION
TABLE 50 LAMEA BREAST CANCER MOLECULAR DIAGNOSTICS MARKET BY COUNTRY, 2016 - 2022, USD MILLION
TABLE 51 LAMEA COLORECTAL CANCER MOLECULAR DIAGNOSTICS MARKET BY COUNTRY, 2012 - 2015, USD MILLION
TABLE 52 LAMEA COLORECTAL CANCER MOLECULAR DIAGNOSTICS MARKET BY COUNTRY, 2016 - 2022, USD MILLION
TABLE 53 LAMEA PROSTATE CANCER MOLECULAR DIAGNOSTICS MARKET BY COUNTRY, 2012 - 2015, USD MILLION
TABLE 54 LAMEA PROSTATE CANCER MOLECULAR DIAGNOSTICS MARKET BY COUNTRY, 2016 - 2022, USD MILLION
TABLE 55 LAMEA OTHER CANCERS MOLECULAR DIAGNOSTICS MARKET BY COUNTRY, 2012 - 2015, USD MILLION
TABLE 56 LAMEA OTHER CANCERS MOLECULAR DIAGNOSTICS MARKET BY COUNTRY, 2016 - 2022, USD MILLION
TABLE 57 LAMEA BLOOD SCREENING MOLECULAR DIAGNOSTICS MARKET BY COUNTRY, 2012 - 2015, USD MILLION
TABLE 58 LAMEA BLOOD SCREENING MOLECULAR DIAGNOSTICS MARKET BY COUNTRY, 2016 - 2022, USD MILLION
TABLE 59 LAMEA GENETIC TESTS MOLECULAR DIAGNOSTICS MARKET BY COUNTRY, 2012 - 2015, USD MILLION
TABLE 60 LAMEA GENETIC TESTS MOLECULAR DIAGNOSTICS MARKET BY COUNTRY, 2016 - 2022, USD MILLION
TABLE 61 LAMEA MICROBIOLOGY MOLECULAR DIAGNOSTICS MARKET BY COUNTRY, 2012 - 2015, USD MILLION
TABLE 62 LAMEA MICROBIOLOGY MOLECULAR DIAGNOSTICS MARKET BY COUNTRY, 2016 - 2022, USD MILLION
TABLE 63 LAMEA OTHER APPLICATIONS MARKET BY COUNTRY, 2012 - 2015, USD MILLION
TABLE 64 LAMEA OTHER APPLICATIONS MARKET BY COUNTRY, 2016 - 2022, USD MILLION
TABLE 65 LAMEA MOLECULAR DIAGNOSTICS MARKET BY END USER, 2012 - 2015, USD MILLION
TABLE 66 LAMEA MOLECULAR DIAGNOSTICS MARKET BY END USER, 2016 - 2022, USD MILLION
TABLE 67 LAMEA MOLECULAR DIAGNOSTICS MARKET FOR HOSPITAL & ACADEMIC LABORATORIES BY COUNTRY, 2012 - 2015, USD MILLION
TABLE 68 LAMEA MOLECULAR DIAGNOSTICS MARKET FOR HOSPITAL & ACADEMIC LABORATORIES BY COUNTRY, 2016 - 2022, USD MILLION
TABLE 69 LAMEA MOLECULAR DIAGNOSTICS MARKET FOR REFERENCE LABORATORIES BY COUNTRY, 2012 - 2015, USD MILLION
TABLE 70 LAMEA MOLECULAR DIAGNOSTICS MARKET FOR REFERENCE LABORATORIES BY COUNTRY, 2016 - 2022, USD MILLION
TABLE 71 LAMEA MOLECULAR DIAGNOSTICS MARKET FOR OTHER END USERS BY COUNTRY, 2012 - 2015, USD MILLION
TABLE 72 LAMEA MOLECULAR DIAGNOSTICS MARKET FOR OTHER END USERS BY COUNTRY, 2016 - 2022, USD MILLION
TABLE 73 LAMEA MOLECULAR DIAGNOSTICS MARKET BY COUNTRY, 2012 - 2015, USD MILLION
TABLE 74 LAMEA MOLECULAR DIAGNOSTICS MARKET BY COUNTRY, 2016 - 2022, USD MILLION
TABLE 75 BRAZIL MOLECULAR DIAGNOSTICS MARKET, 2012 - 2015, USD MILLION
TABLE 76 BRAZIL MOLECULAR DIAGNOSTICS MARKET, 2016 - 2022, USD MILLION
TABLE 77 BRAZIL MOLECULAR DIAGNOSTICS MARKET BY PRODUCT & SERVICES, 2012 - 2015, USD MILLION
TABLE 78 BRAZIL MOLECULAR DIAGNOSTICS MARKET BY PRODUCT & SERVICES, 2016 - 2022, USD MILLION
TABLE 79 BRAZIL MOLECULAR DIAGNOSTICS MARKET BY TECHNOLOGY, 2012 - 2015, USD MILLION
TABLE 80 BRAZIL MOLECULAR DIAGNOSTICS MARKET BY TECHNOLOGY, 2016 - 2022, USD MILLION
TABLE 81 BRAZIL MOLECULAR DIAGNOSTICS MARKET BY APPLICATION 2012 - 2015, USD MILLION
TABLE 82 BRAZIL MOLECULAR DIAGNOSTICS MARKET BY APPLICATION 2016 - 2022, USD MILLION
TABLE 83 BRAZIL INFECTIOUS DISEASES MOLECULAR DIAGNOSTICS MARKET BY TYPE, 2012 - 2015, USD MILLION
TABLE 84 BRAZIL INFECTIOUS DISEASES MOLECULAR DIAGNOSTICS MARKET BY TYPE, 2016 - 2022, USD MILLION
TABLE 85 BRAZIL ONCOLOGY MOLECULAR DIAGNOSTICS MARKET BY TYPE, 2012 - 2015, USD MILLION
TABLE 86 BRAZIL ONCOLOGY MOLECULAR DIAGNOSTICS MARKET BY TYPE, 2016 - 2022, USD MILLION
TABLE 87 BRAZIL MOLECULAR DIAGNOSTICS MARKET BY END USER, 2012 - 2015, USD MILLION
TABLE 88 BRAZIL MOLECULAR DIAGNOSTICS MARKET BY END USER, 2016 - 2022, USD MILLION
TABLE 89 ARGENTINA MOLECULAR DIAGNOSTICS MARKET, 2012 - 2015, USD MILLION
TABLE 90 ARGENTINA MOLECULAR DIAGNOSTICS MARKET, 2016 - 2022, USD MILLION
TABLE 91 ARGENTINA MOLECULAR DIAGNOSTICS MARKET BY PRODUCT & SERVICES, 2012 - 2015, USD MILLION
TABLE 92 ARGENTINA MOLECULAR DIAGNOSTICS MARKET BY PRODUCT & SERVICES, 2016 - 2022, USD MILLION
TABLE 93 ARGENTINA MOLECULAR DIAGNOSTICS MARKET BY TECHNOLOGY, 2012 - 2015, USD MILLION
TABLE 94 ARGENTINA MOLECULAR DIAGNOSTICS MARKET BY TECHNOLOGY, 2016 - 2022, USD MILLION
TABLE 95 ARGENTINA MOLECULAR DIAGNOSTICS MARKET BY APPLICATION 2012 - 2015, USD MILLION
TABLE 96 ARGENTINA MOLECULAR DIAGNOSTICS MARKET BY APPLICATION 2016 - 2022, USD MILLION
TABLE 97 ARGENTINA INFECTIOUS DISEASES MOLECULAR DIAGNOSTICS MARKET BY TYPE, 2012 - 2015, USD MILLION
TABLE 98 ARGENTINA INFECTIOUS DISEASES MOLECULAR DIAGNOSTICS MARKET BY TYPE, 2016 - 2022, USD MILLION
TABLE 99 ARGENTINA ONCOLOGY MOLECULAR DIAGNOSTICS MARKET BY TYPE, 2012 - 2015, USD MILLION
TABLE 100 ARGENTINA ONCOLOGY MOLECULAR DIAGNOSTICS MARKET BY TYPE, 2016 - 2022, USD MILLION
TABLE 101 ARGENTINA MOLECULAR DIAGNOSTICS MARKET BY END USER, 2012 - 2015, USD MILLION
TABLE 102 ARGENTINA MOLECULAR DIAGNOSTICS MARKET BY END USER, 2016 - 2022, USD MILLION
TABLE 103 UAE MOLECULAR DIAGNOSTICS MARKET, 2012 - 2015, USD MILLION
TABLE 104 UAE MOLECULAR DIAGNOSTICS MARKET, 2016 - 2022, USD MILLION
TABLE 105 UAE MOLECULAR DIAGNOSTICS MARKET BY PRODUCT & SERVICES, 2012 - 2015, USD MILLION
TABLE 106 UAE MOLECULAR DIAGNOSTICS MARKET BY PRODUCT & SERVICES, 2016 - 2022, USD MILLION
TABLE 107 UAE MOLECULAR DIAGNOSTICS MARKET BY TECHNOLOGY, 2012 - 2015, USD MILLION
TABLE 108 UAE MOLECULAR DIAGNOSTICS MARKET BY TECHNOLOGY, 2016 - 2022, USD MILLION
TABLE 109 UAE MOLECULAR DIAGNOSTICS MARKET BY APPLICATION 2012 - 2015, USD MILLION
TABLE 110 UAE MOLECULAR DIAGNOSTICS MARKET BY APPLICATION 2016 - 2022, USD MILLION
TABLE 111 UAE INFECTIOUS DISEASES MOLECULAR DIAGNOSTICS MARKET BY TYPE, 2012 - 2015, USD MILLION
TABLE 112 UAE INFECTIOUS DISEASES MOLECULAR DIAGNOSTICS MARKET BY TYPE, 2016 - 2022, USD MILLION
TABLE 113 UAE ONCOLOGY MOLECULAR DIAGNOSTICS MARKET BY TYPE, 2012 - 2015, USD MILLION
TABLE 114 UAE ONCOLOGY MOLECULAR DIAGNOSTICS MARKET BY TYPE, 2016 - 2022, USD MILLION
TABLE 115 UAE MOLECULAR DIAGNOSTICS MARKET BY END USER, 2012 - 2015, USD MILLION
TABLE 116 UAE MOLECULAR DIAGNOSTICS MARKET BY END USER, 2016 - 2022, USD MILLION
TABLE 117 SAUDI ARABIA MOLECULAR DIAGNOSTICS MARKET, 2012 - 2015, USD MILLION
TABLE 118 SAUDI ARABIA MOLECULAR DIAGNOSTICS MARKET, 2016 - 2022, USD MILLION
TABLE 119 SAUDI ARABIA MOLECULAR DIAGNOSTICS MARKET BY PRODUCT & SERVICES, 2012 - 2015, USD MILLION
TABLE 120 SAUDI ARABIA MOLECULAR DIAGNOSTICS MARKET BY PRODUCT & SERVICES, 2016 - 2022, USD MILLION
TABLE 121 SAUDI ARABIA MOLECULAR DIAGNOSTICS MARKET BY TECHNOLOGY, 2012 - 2015, USD MILLION
TABLE 122 SAUDI ARABIA MOLECULAR DIAGNOSTICS MARKET BY TECHNOLOGY, 2016 - 2022, USD MILLION
TABLE 123 SAUDI ARABIA MOLECULAR DIAGNOSTICS MARKET BY APPLICATION 2012 - 2015, USD MILLION
TABLE 124 SAUDI ARABIA MOLECULAR DIAGNOSTICS MARKET BY APPLICATION 2016 - 2022, USD MILLION
TABLE 125 SAUDI ARABIA INFECTIOUS DISEASES MOLECULAR DIAGNOSTICS MARKET BY TYPE, 2012 - 2015, USD MILLION
TABLE 126 SAUDI ARABIA INFECTIOUS DISEASES MOLECULAR DIAGNOSTICS MARKET BY TYPE, 2016 - 2022, USD MILLION
TABLE 127 SAUDI ARABIA ONCOLOGY MOLECULAR DIAGNOSTICS MARKET BY TYPE, 2012 - 2015, USD MILLION
TABLE 128 SAUDI ARABIA ONCOLOGY MOLECULAR DIAGNOSTICS MARKET BY TYPE, 2016 - 2022, USD MILLION
TABLE 129 SAUDI ARABIA MOLECULAR DIAGNOSTICS MARKET BY END USER, 2012 - 2015, USD MILLION
TABLE 130 SAUDI ARABIA MOLECULAR DIAGNOSTICS MARKET BY END USER, 2016 - 2022, USD MILLION
TABLE 131 SOUTH AFRICA MOLECULAR DIAGNOSTICS MARKET, 2012 - 2015, USD MILLION
TABLE 132 SOUTH AFRICA MOLECULAR DIAGNOSTICS MARKET, 2016 - 2022, USD MILLION
TABLE 133 SOUTH AFRICA MOLECULAR DIAGNOSTICS MARKET BY PRODUCT & SERVICES, 2012 - 2015, USD MILLION
TABLE 134 SOUTH AFRICA MOLECULAR DIAGNOSTICS MARKET BY PRODUCT & SERVICES, 2016 - 2022, USD MILLION
TABLE 135 SOUTH AFRICA MOLECULAR DIAGNOSTICS MARKET BY TECHNOLOGY, 2012 - 2015, USD MILLION
TABLE 136 SOUTH AFRICA MOLECULAR DIAGNOSTICS MARKET BY TECHNOLOGY, 2016 - 2022, USD MILLION
TABLE 137 SOUTH AFRICA MOLECULAR DIAGNOSTICS MARKET BY APPLICATION 2012 - 2015, USD MILLION
TABLE 138 SOUTH AFRICA MOLECULAR DIAGNOSTICS MARKET BY APPLICATION 2016 - 2022, USD MILLION
TABLE 139 SOUTH AFRICA INFECTIOUS DISEASES MOLECULAR DIAGNOSTICS MARKET BY TYPE, 2012 - 2015, USD MILLION
TABLE 140 SOUTH AFRICA INFECTIOUS DISEASES MOLECULAR DIAGNOSTICS MARKET BY TYPE, 2016 - 2022, USD MILLION
TABLE 141 SOUTH AFRICA ONCOLOGY MOLECULAR DIAGNOSTICS MARKET BY TYPE, 2012 - 2015, USD MILLION
TABLE 142 SOUTH AFRICA ONCOLOGY MOLECULAR DIAGNOSTICS MARKET BY TYPE, 2016 - 2022, USD MILLION
TABLE 143 SOUTH AFRICA MOLECULAR DIAGNOSTICS MARKET BY END USER, 2012 - 2015, USD MILLION
TABLE 144 SOUTH AFRICA MOLECULAR DIAGNOSTICS MARKET BY END USER, 2016 - 2022, USD MILLION
TABLE 145 NIGERIA MOLECULAR DIAGNOSTICS MARKET, 2012 - 2015, USD MILLION
TABLE 146 NIGERIA MOLECULAR DIAGNOSTICS MARKET, 2016 - 2022, USD MILLION
TABLE 147 NIGERIA MOLECULAR DIAGNOSTICS MARKET BY PRODUCT & SERVICES, 2012 - 2015, USD MILLION
TABLE 148 NIGERIA MOLECULAR DIAGNOSTICS MARKET BY PRODUCT & SERVICES, 2016 - 2022, USD MILLION
TABLE 149 NIGERIA MOLECULAR DIAGNOSTICS MARKET BY TECHNOLOGY, 2012 - 2015, USD MILLION
TABLE 150 NIGERIA MOLECULAR DIAGNOSTICS MARKET BY TECHNOLOGY, 2016 - 2022, USD MILLION
TABLE 151 NIGERIA MOLECULAR DIAGNOSTICS MARKET BY APPLICATION 2012 - 2015, USD MILLION
TABLE 152 NIGERIA MOLECULAR DIAGNOSTICS MARKET BY APPLICATION 2016 - 2022, USD MILLION
TABLE 153 NIGERIA INFECTIOUS DISEASES MOLECULAR DIAGNOSTICS MARKET BY TYPE, 2012 - 2015, USD MILLION
TABLE 154 NIGERIA INFECTIOUS DISEASES MOLECULAR DIAGNOSTICS MARKET BY TYPE, 2016 - 2022, USD MILLION
TABLE 155 NIGERIA ONCOLOGY MOLECULAR DIAGNOSTICS MARKET BY TYPE, 2012 - 2015, USD MILLION
TABLE 156 NIGERIA ONCOLOGY MOLECULAR DIAGNOSTICS MARKET BY TYPE, 2016 - 2022, USD MILLION
TABLE 157 NIGERIA MOLECULAR DIAGNOSTICS MARKET BY END USER, 2012 - 2015, USD MILLION
TABLE 158 NIGERIA MOLECULAR DIAGNOSTICS MARKET BY END USER, 2016 - 2022, USD MILLION
TABLE 159 REST OF LAMEA MOLECULAR DIAGNOSTICS MARKET, 2012 - 2015, USD MILLION
TABLE 160 REST OF LAMEA MOLECULAR DIAGNOSTICS MARKET, 2016 - 2022, USD MILLION
TABLE 161 REST OF LAMEA MOLECULAR DIAGNOSTICS MARKET BY PRODUCT & SERVICES, 2012 - 2015, USD MILLION
TABLE 162 REST OF LAMEA MOLECULAR DIAGNOSTICS MARKET BY PRODUCT & SERVICES, 2016 - 2022, USD MILLION
TABLE 163 REST OF LAMEA MOLECULAR DIAGNOSTICS MARKET BY TECHNOLOGY, 2012 - 2015, USD MILLION
TABLE 164 REST OF LAMEA MOLECULAR DIAGNOSTICS MARKET BY TECHNOLOGY, 2016 - 2022, USD MILLION
TABLE 165 REST OF LAMEA MOLECULAR DIAGNOSTICS MARKET BY APPLICATION 2012 - 2015, USD MILLION
TABLE 166 REST OF LAMEA MOLECULAR DIAGNOSTICS MARKET BY APPLICATION 2016 - 2022, USD MILLION
TABLE 167 REST OF LAMEA INFECTIOUS DISEASES MOLECULAR DIAGNOSTICS MARKET BY TYPE, 2012 - 2015, USD MILLION
TABLE 168 REST OF LAMEA INFECTIOUS DISEASES MOLECULAR DIAGNOSTICS MARKET BY TYPE, 2016 - 2022, USD MILLION
TABLE 169 REST OF LAMEA ONCOLOGY MOLECULAR DIAGNOSTICS MARKET BY TYPE, 2012 - 2015, USD MILLION
TABLE 170 REST OF LAMEA ONCOLOGY MOLECULAR DIAGNOSTICS MARKET BY TYPE, 2016 - 2022, USD MILLION
TABLE 171 REST OF LAMEA MOLECULAR DIAGNOSTICS MARKET BY END USER, 2012 - 2015, USD MILLION
TABLE 172 REST OF LAMEA MOLECULAR DIAGNOSTICS MARKET BY END USER, 2016 - 2022, USD MILLION
TABLE 173 KEY INFORMATION – ABBOTT LABORATORIES.
TABLE 174 KEY INFORMATION – QUIAGEN N.V.
TABLE 175 KEY INFORMATION – ROCHE DIAGNOSTIC
TABLE 176 KEY INFORMATION – GRIFOLS
TABLE 177 KEY INFORMATION – SIEMENS HEALTHCARE (SIEMENS AG)
TABLE 178 KEY INFORMATION – BECTON DICKINSON AND COMPANY
TABLE 179 KEY INFORMATION – DANAHER CORPORATION
TABLE 1 LAMEA MOLECULAR DIAGNOSTICS MARKET, 2012 - 2015, USD MILLION
TABLE 2 LAMEA MOLECULAR DIAGNOSTICS MARKET, 2016 - 2022, USD MILLION
TABLE 3 LAMEA MOLECULAR DIAGNOSTICS MARKET BY PRODUCT & SERVICES, 2012 - 2015, USD MILLION
TABLE 4 LAMEA MOLECULAR DIAGNOSTICS MARKET BY PRODUCT & SERVICES, 2016 - 2022, USD MILLION
TABLE 5 LAMEA MOLECULAR DIAGNOSTICS REAGENTS & KITS MARKET BY COUNTRY, 2012 - 2015, USD MILLION
TABLE 6 LAMEA MOLECULAR DIAGNOSTICS REAGENTS & KITS MARKET BY COUNTRY, 2016 - 2022, USD MILLION
TABLE 7 LAMEA MOLECULAR DIAGNOSTICS INSTRUMENTS MARKET BY COUNTRY, 2012 - 2015, USD MILLION
TABLE 8 LAMEA MOLECULAR DIAGNOSTICS INSTRUMENTS MARKET BY COUNTRY, 2016 - 2022, USD MILLION
TABLE 9 LAMEA MOLECULAR DIAGNOSTICS SOFTWARE & SERVICES MARKET BY COUNTRY, 2012 - 2015, USD MILLION
TABLE 10 LAMEA MOLECULAR DIAGNOSTICS SOFTWARE & SERVICES MARKET BY COUNTRY, 2016 - 2022, USD MILLION
TABLE 11 LAMEA MOLECULAR DIAGNOSTICS MARKET BY TECHNOLOGY, 2012 - 2015, USD MILLION
TABLE 12 LAMEA MOLECULAR DIAGNOSTICS MARKET BY TECHNOLOGY, 2016 - 2022, USD MILLION
TABLE 13 LAMEA POLYMERASE CHAIN REACTION MOLECULAR DIAGNOSTICS MARKET BY COUNTRY, 2012 - 2015, USD MILLION
TABLE 14 LAMEA POLYMERASE CHAIN REACTION MOLECULAR DIAGNOSTICS MARKET BY COUNTRY, 2016 - 2022, USD MILLION
TABLE 15 LAMEA ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MOLECULAR DIAGNOSTICS MARKET BY COUNTRY, 2012 - 2015, USD MILLION
TABLE 16 LAMEA ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MOLECULAR DIAGNOSTICS MARKET BY COUNTRY, 2016 - 2022, USD MILLION
TABLE 17 LAMEA HYBRIDIZATION MOLECULAR DIAGNOSTICS MARKET BY COUNTRY, 2012 - 2015, USD MILLION
TABLE 18 LAMEA HYBRIDIZATION MOLECULAR DIAGNOSTICS MARKET BY COUNTRY, 2016 - 2022, USD MILLION
TABLE 19 LAMEA DNA SEQUENCING & NEXT-GENERATION SEQUENCING MOLECULAR DIAGNOSTICS MARKET BY COUNTRY, 2012 - 2015, USD MILLION
TABLE 20 LAMEA DNA SEQUENCING & NEXT-GENERATION SEQUENCING MOLECULAR DIAGNOSTICS MARKET BY COUNTRY, 2016 - 2022, USD MILLION
TABLE 21 LAMEA MICROARRAY MOLECULAR DIAGNOSTICS MARKET BY COUNTRY, 2012 - 2015, USD MILLION
TABLE 22 LAMEA MICROARRAY MOLECULAR DIAGNOSTICS MARKET BY COUNTRY, 2016 - 2022, USD MILLION
TABLE 23 LAMEA OTHER TECHNOLOGIES MARKET BY COUNTRY, 2012 - 2015, USD MILLION
TABLE 24 LAMEA OTHER TECHNOLOGIES MARKET BY COUNTRY, 2016 - 2022, USD MILLION
TABLE 25 LAMEA MOLECULAR DIAGNOSTICS MARKET BY APPLICATION 2012 - 2015, USD MILLION
TABLE 26 LAMEA MOLECULAR DIAGNOSTICS MARKET BY APPLICATION 2016 - 2022, USD MILLION
TABLE 27 LAMEA INFECTIOUS DISEASES MOLECULAR DIAGNOSTICS MARKET BY COUNTRY, 2012 - 2015, USD MILLION
TABLE 28 LAMEA INFECTIOUS DISEASES MOLECULAR DIAGNOSTICS MARKET BY COUNTRY, 2016 - 2022, USD MILLION
TABLE 29 LAMEA INFECTIOUS DISEASES MOLECULAR DIAGNOSTICS MARKET BY TYPE, 2012 - 2015, USD MILLION
TABLE 30 LAMEA INFECTIOUS DISEASES MOLECULAR DIAGNOSTICS MARKET BY TYPE, 2016 - 2022, USD MILLION
TABLE 31 LAMEA CHLAMYDIA TRACHOMATIS & NEISSERIA GONORRHEA MOLECULAR DIAGNOSTICS MARKET BY COUNTRY, 2012 - 2015, USD MILLION
TABLE 32 LAMEA CHLAMYDIA TRACHOMATIS & NEISSERIA GONORRHEA MOLECULAR DIAGNOSTICS MARKET BY COUNTRY, 2016 - 2022, USD MILLION
TABLE 33 LAMEA HEPATITIS B & HEPATITIS C MOLECULAR DIAGNOSTICS MARKET BY COUNTRY, 2012 - 2015, USD MILLION
TABLE 34 LAMEA HEPATITIS B & HEPATITIS C MOLECULAR DIAGNOSTICS MARKET BY COUNTRY, 2016 - 2022, USD MILLION
TABLE 35 LAMEA HUMAN PAPILLOMAVIRUS MOLECULAR DIAGNOSTICS MARKET BY COUNTRY, 2012 - 2015, USD MILLION
TABLE 36 LAMEA HUMAN PAPILLOMAVIRUS MOLECULAR DIAGNOSTICS MARKET BY COUNTRY, 2016 - 2022, USD MILLION
TABLE 37 LAMEA HUMAN IMMUNODEFICIENCY VIRUS MOLECULAR DIAGNOSTICS MARKET BY COUNTRY, 2012 - 2015, USD MILLION
TABLE 38 LAMEA HUMAN IMMUNODEFICIENCY VIRUS MOLECULAR DIAGNOSTICS MARKET BY COUNTRY, 2016 - 2022, USD MILLION
TABLE 39 LAMEA TUBERCULOSIS MOLECULAR DIAGNOSTICS MARKET BY COUNTRY, 2012 - 2015, USD MILLION
TABLE 40 LAMEA TUBERCULOSIS MOLECULAR DIAGNOSTICS MARKET BY COUNTRY, 2016 - 2022, USD MILLION
TABLE 41 LAMEA METHICILLIN-RESISTANT STAPHYLOCOCCUS AUROUS MOLECULAR DIAGNOSTICS MARKET BY COUNTRY, 2012 - 2015, USD MILLION
TABLE 42 LAMEA METHICILLIN-RESISTANT STAPHYLOCOCCUS AUROUS MOLECULAR DIAGNOSTICS MARKET BY COUNTRY, 2016 - 2022, USD MILLION
TABLE 43 LAMEA MOLECULAR DIAGNOSTICS IN OTHER INFECTIOUS DISEASES MARKET BY COUNTRY, 2012 - 2015, USD MILLION
TABLE 44 LAMEA MOLECULAR DIAGNOSTICS IN OTHER INFECTIOUS DISEASES MARKET BY COUNTRY, 2016 - 2022, USD MILLION
TABLE 45 LAMEA ONCOLOGY MOLECULAR DIAGNOSTICS MARKET BY COUNTRY, 2012 - 2015, USD MILLION
TABLE 46 LAMEA ONCOLOGY MOLECULAR DIAGNOSTICS MARKET BY COUNTRY, 2016 - 2022, USD MILLION
TABLE 47 LAMEA ONCOLOGY MOLECULAR DIAGNOSTICS MARKET BY TYPE, 2012 - 2015, USD MILLION
TABLE 48 LAMEA ONCOLOGY MOLECULAR DIAGNOSTICS MARKET BY TYPE, 2016 - 2022, USD MILLION
TABLE 49 LAMEA BREAST CANCER MOLECULAR DIAGNOSTICS MARKET BY COUNTRY, 2012 - 2015, USD MILLION
TABLE 50 LAMEA BREAST CANCER MOLECULAR DIAGNOSTICS MARKET BY COUNTRY, 2016 - 2022, USD MILLION
TABLE 51 LAMEA COLORECTAL CANCER MOLECULAR DIAGNOSTICS MARKET BY COUNTRY, 2012 - 2015, USD MILLION
TABLE 52 LAMEA COLORECTAL CANCER MOLECULAR DIAGNOSTICS MARKET BY COUNTRY, 2016 - 2022, USD MILLION
TABLE 53 LAMEA PROSTATE CANCER MOLECULAR DIAGNOSTICS MARKET BY COUNTRY, 2012 - 2015, USD MILLION
TABLE 54 LAMEA PROSTATE CANCER MOLECULAR DIAGNOSTICS MARKET BY COUNTRY, 2016 - 2022, USD MILLION
TABLE 55 LAMEA OTHER CANCERS MOLECULAR DIAGNOSTICS MARKET BY COUNTRY, 2012 - 2015, USD MILLION
TABLE 56 LAMEA OTHER CANCERS MOLECULAR DIAGNOSTICS MARKET BY COUNTRY, 2016 - 2022, USD MILLION
TABLE 57 LAMEA BLOOD SCREENING MOLECULAR DIAGNOSTICS MARKET BY COUNTRY, 2012 - 2015, USD MILLION
TABLE 58 LAMEA BLOOD SCREENING MOLECULAR DIAGNOSTICS MARKET BY COUNTRY, 2016 - 2022, USD MILLION
TABLE 59 LAMEA GENETIC TESTS MOLECULAR DIAGNOSTICS MARKET BY COUNTRY, 2012 - 2015, USD MILLION
TABLE 60 LAMEA GENETIC TESTS MOLECULAR DIAGNOSTICS MARKET BY COUNTRY, 2016 - 2022, USD MILLION
TABLE 61 LAMEA MICROBIOLOGY MOLECULAR DIAGNOSTICS MARKET BY COUNTRY, 2012 - 2015, USD MILLION
TABLE 62 LAMEA MICROBIOLOGY MOLECULAR DIAGNOSTICS MARKET BY COUNTRY, 2016 - 2022, USD MILLION
TABLE 63 LAMEA OTHER APPLICATIONS MARKET BY COUNTRY, 2012 - 2015, USD MILLION
TABLE 64 LAMEA OTHER APPLICATIONS MARKET BY COUNTRY, 2016 - 2022, USD MILLION
TABLE 65 LAMEA MOLECULAR DIAGNOSTICS MARKET BY END USER, 2012 - 2015, USD MILLION
TABLE 66 LAMEA MOLECULAR DIAGNOSTICS MARKET BY END USER, 2016 - 2022, USD MILLION
TABLE 67 LAMEA MOLECULAR DIAGNOSTICS MARKET FOR HOSPITAL & ACADEMIC LABORATORIES BY COUNTRY, 2012 - 2015, USD MILLION
TABLE 68 LAMEA MOLECULAR DIAGNOSTICS MARKET FOR HOSPITAL & ACADEMIC LABORATORIES BY COUNTRY, 2016 - 2022, USD MILLION
TABLE 69 LAMEA MOLECULAR DIAGNOSTICS MARKET FOR REFERENCE LABORATORIES BY COUNTRY, 2012 - 2015, USD MILLION
TABLE 70 LAMEA MOLECULAR DIAGNOSTICS MARKET FOR REFERENCE LABORATORIES BY COUNTRY, 2016 - 2022, USD MILLION
TABLE 71 LAMEA MOLECULAR DIAGNOSTICS MARKET FOR OTHER END USERS BY COUNTRY, 2012 - 2015, USD MILLION
TABLE 72 LAMEA MOLECULAR DIAGNOSTICS MARKET FOR OTHER END USERS BY COUNTRY, 2016 - 2022, USD MILLION
TABLE 73 LAMEA MOLECULAR DIAGNOSTICS MARKET BY COUNTRY, 2012 - 2015, USD MILLION
TABLE 74 LAMEA MOLECULAR DIAGNOSTICS MARKET BY COUNTRY, 2016 - 2022, USD MILLION
TABLE 75 BRAZIL MOLECULAR DIAGNOSTICS MARKET, 2012 - 2015, USD MILLION
TABLE 76 BRAZIL MOLECULAR DIAGNOSTICS MARKET, 2016 - 2022, USD MILLION
TABLE 77 BRAZIL MOLECULAR DIAGNOSTICS MARKET BY PRODUCT & SERVICES, 2012 - 2015, USD MILLION
TABLE 78 BRAZIL MOLECULAR DIAGNOSTICS MARKET BY PRODUCT & SERVICES, 2016 - 2022, USD MILLION
TABLE 79 BRAZIL MOLECULAR DIAGNOSTICS MARKET BY TECHNOLOGY, 2012 - 2015, USD MILLION
TABLE 80 BRAZIL MOLECULAR DIAGNOSTICS MARKET BY TECHNOLOGY, 2016 - 2022, USD MILLION
TABLE 81 BRAZIL MOLECULAR DIAGNOSTICS MARKET BY APPLICATION 2012 - 2015, USD MILLION
TABLE 82 BRAZIL MOLECULAR DIAGNOSTICS MARKET BY APPLICATION 2016 - 2022, USD MILLION
TABLE 83 BRAZIL INFECTIOUS DISEASES MOLECULAR DIAGNOSTICS MARKET BY TYPE, 2012 - 2015, USD MILLION
TABLE 84 BRAZIL INFECTIOUS DISEASES MOLECULAR DIAGNOSTICS MARKET BY TYPE, 2016 - 2022, USD MILLION
TABLE 85 BRAZIL ONCOLOGY MOLECULAR DIAGNOSTICS MARKET BY TYPE, 2012 - 2015, USD MILLION
TABLE 86 BRAZIL ONCOLOGY MOLECULAR DIAGNOSTICS MARKET BY TYPE, 2016 - 2022, USD MILLION
TABLE 87 BRAZIL MOLECULAR DIAGNOSTICS MARKET BY END USER, 2012 - 2015, USD MILLION
TABLE 88 BRAZIL MOLECULAR DIAGNOSTICS MARKET BY END USER, 2016 - 2022, USD MILLION
TABLE 89 ARGENTINA MOLECULAR DIAGNOSTICS MARKET, 2012 - 2015, USD MILLION
TABLE 90 ARGENTINA MOLECULAR DIAGNOSTICS MARKET, 2016 - 2022, USD MILLION
TABLE 91 ARGENTINA MOLECULAR DIAGNOSTICS MARKET BY PRODUCT & SERVICES, 2012 - 2015, USD MILLION
TABLE 92 ARGENTINA MOLECULAR DIAGNOSTICS MARKET BY PRODUCT & SERVICES, 2016 - 2022, USD MILLION
TABLE 93 ARGENTINA MOLECULAR DIAGNOSTICS MARKET BY TECHNOLOGY, 2012 - 2015, USD MILLION
TABLE 94 ARGENTINA MOLECULAR DIAGNOSTICS MARKET BY TECHNOLOGY, 2016 - 2022, USD MILLION
TABLE 95 ARGENTINA MOLECULAR DIAGNOSTICS MARKET BY APPLICATION 2012 - 2015, USD MILLION
TABLE 96 ARGENTINA MOLECULAR DIAGNOSTICS MARKET BY APPLICATION 2016 - 2022, USD MILLION
TABLE 97 ARGENTINA INFECTIOUS DISEASES MOLECULAR DIAGNOSTICS MARKET BY TYPE, 2012 - 2015, USD MILLION
TABLE 98 ARGENTINA INFECTIOUS DISEASES MOLECULAR DIAGNOSTICS MARKET BY TYPE, 2016 - 2022, USD MILLION
TABLE 99 ARGENTINA ONCOLOGY MOLECULAR DIAGNOSTICS MARKET BY TYPE, 2012 - 2015, USD MILLION
TABLE 100 ARGENTINA ONCOLOGY MOLECULAR DIAGNOSTICS MARKET BY TYPE, 2016 - 2022, USD MILLION
TABLE 101 ARGENTINA MOLECULAR DIAGNOSTICS MARKET BY END USER, 2012 - 2015, USD MILLION
TABLE 102 ARGENTINA MOLECULAR DIAGNOSTICS MARKET BY END USER, 2016 - 2022, USD MILLION
TABLE 103 UAE MOLECULAR DIAGNOSTICS MARKET, 2012 - 2015, USD MILLION
TABLE 104 UAE MOLECULAR DIAGNOSTICS MARKET, 2016 - 2022, USD MILLION
TABLE 105 UAE MOLECULAR DIAGNOSTICS MARKET BY PRODUCT & SERVICES, 2012 - 2015, USD MILLION
TABLE 106 UAE MOLECULAR DIAGNOSTICS MARKET BY PRODUCT & SERVICES, 2016 - 2022, USD MILLION
TABLE 107 UAE MOLECULAR DIAGNOSTICS MARKET BY TECHNOLOGY, 2012 - 2015, USD MILLION
TABLE 108 UAE MOLECULAR DIAGNOSTICS MARKET BY TECHNOLOGY, 2016 - 2022, USD MILLION
TABLE 109 UAE MOLECULAR DIAGNOSTICS MARKET BY APPLICATION 2012 - 2015, USD MILLION
TABLE 110 UAE MOLECULAR DIAGNOSTICS MARKET BY APPLICATION 2016 - 2022, USD MILLION
TABLE 111 UAE INFECTIOUS DISEASES MOLECULAR DIAGNOSTICS MARKET BY TYPE, 2012 - 2015, USD MILLION
TABLE 112 UAE INFECTIOUS DISEASES MOLECULAR DIAGNOSTICS MARKET BY TYPE, 2016 - 2022, USD MILLION
TABLE 113 UAE ONCOLOGY MOLECULAR DIAGNOSTICS MARKET BY TYPE, 2012 - 2015, USD MILLION
TABLE 114 UAE ONCOLOGY MOLECULAR DIAGNOSTICS MARKET BY TYPE, 2016 - 2022, USD MILLION
TABLE 115 UAE MOLECULAR DIAGNOSTICS MARKET BY END USER, 2012 - 2015, USD MILLION
TABLE 116 UAE MOLECULAR DIAGNOSTICS MARKET BY END USER, 2016 - 2022, USD MILLION
TABLE 117 SAUDI ARABIA MOLECULAR DIAGNOSTICS MARKET, 2012 - 2015, USD MILLION
TABLE 118 SAUDI ARABIA MOLECULAR DIAGNOSTICS MARKET, 2016 - 2022, USD MILLION
TABLE 119 SAUDI ARABIA MOLECULAR DIAGNOSTICS MARKET BY PRODUCT & SERVICES, 2012 - 2015, USD MILLION
TABLE 120 SAUDI ARABIA MOLECULAR DIAGNOSTICS MARKET BY PRODUCT & SERVICES, 2016 - 2022, USD MILLION
TABLE 121 SAUDI ARABIA MOLECULAR DIAGNOSTICS MARKET BY TECHNOLOGY, 2012 - 2015, USD MILLION
TABLE 122 SAUDI ARABIA MOLECULAR DIAGNOSTICS MARKET BY TECHNOLOGY, 2016 - 2022, USD MILLION
TABLE 123 SAUDI ARABIA MOLECULAR DIAGNOSTICS MARKET BY APPLICATION 2012 - 2015, USD MILLION
TABLE 124 SAUDI ARABIA MOLECULAR DIAGNOSTICS MARKET BY APPLICATION 2016 - 2022, USD MILLION
TABLE 125 SAUDI ARABIA INFECTIOUS DISEASES MOLECULAR DIAGNOSTICS MARKET BY TYPE, 2012 - 2015, USD MILLION
TABLE 126 SAUDI ARABIA INFECTIOUS DISEASES MOLECULAR DIAGNOSTICS MARKET BY TYPE, 2016 - 2022, USD MILLION
TABLE 127 SAUDI ARABIA ONCOLOGY MOLECULAR DIAGNOSTICS MARKET BY TYPE, 2012 - 2015, USD MILLION
TABLE 128 SAUDI ARABIA ONCOLOGY MOLECULAR DIAGNOSTICS MARKET BY TYPE, 2016 - 2022, USD MILLION
TABLE 129 SAUDI ARABIA MOLECULAR DIAGNOSTICS MARKET BY END USER, 2012 - 2015, USD MILLION
TABLE 130 SAUDI ARABIA MOLECULAR DIAGNOSTICS MARKET BY END USER, 2016 - 2022, USD MILLION
TABLE 131 SOUTH AFRICA MOLECULAR DIAGNOSTICS MARKET, 2012 - 2015, USD MILLION
TABLE 132 SOUTH AFRICA MOLECULAR DIAGNOSTICS MARKET, 2016 - 2022, USD MILLION
TABLE 133 SOUTH AFRICA MOLECULAR DIAGNOSTICS MARKET BY PRODUCT & SERVICES, 2012 - 2015, USD MILLION
TABLE 134 SOUTH AFRICA MOLECULAR DIAGNOSTICS MARKET BY PRODUCT & SERVICES, 2016 - 2022, USD MILLION
TABLE 135 SOUTH AFRICA MOLECULAR DIAGNOSTICS MARKET BY TECHNOLOGY, 2012 - 2015, USD MILLION
TABLE 136 SOUTH AFRICA MOLECULAR DIAGNOSTICS MARKET BY TECHNOLOGY, 2016 - 2022, USD MILLION
TABLE 137 SOUTH AFRICA MOLECULAR DIAGNOSTICS MARKET BY APPLICATION 2012 - 2015, USD MILLION
TABLE 138 SOUTH AFRICA MOLECULAR DIAGNOSTICS MARKET BY APPLICATION 2016 - 2022, USD MILLION
TABLE 139 SOUTH AFRICA INFECTIOUS DISEASES MOLECULAR DIAGNOSTICS MARKET BY TYPE, 2012 - 2015, USD MILLION
TABLE 140 SOUTH AFRICA INFECTIOUS DISEASES MOLECULAR DIAGNOSTICS MARKET BY TYPE, 2016 - 2022, USD MILLION
TABLE 141 SOUTH AFRICA ONCOLOGY MOLECULAR DIAGNOSTICS MARKET BY TYPE, 2012 - 2015, USD MILLION
TABLE 142 SOUTH AFRICA ONCOLOGY MOLECULAR DIAGNOSTICS MARKET BY TYPE, 2016 - 2022, USD MILLION
TABLE 143 SOUTH AFRICA MOLECULAR DIAGNOSTICS MARKET BY END USER, 2012 - 2015, USD MILLION
TABLE 144 SOUTH AFRICA MOLECULAR DIAGNOSTICS MARKET BY END USER, 2016 - 2022, USD MILLION
TABLE 145 NIGERIA MOLECULAR DIAGNOSTICS MARKET, 2012 - 2015, USD MILLION
TABLE 146 NIGERIA MOLECULAR DIAGNOSTICS MARKET, 2016 - 2022, USD MILLION
TABLE 147 NIGERIA MOLECULAR DIAGNOSTICS MARKET BY PRODUCT & SERVICES, 2012 - 2015, USD MILLION
TABLE 148 NIGERIA MOLECULAR DIAGNOSTICS MARKET BY PRODUCT & SERVICES, 2016 - 2022, USD MILLION
TABLE 149 NIGERIA MOLECULAR DIAGNOSTICS MARKET BY TECHNOLOGY, 2012 - 2015, USD MILLION
TABLE 150 NIGERIA MOLECULAR DIAGNOSTICS MARKET BY TECHNOLOGY, 2016 - 2022, USD MILLION
TABLE 151 NIGERIA MOLECULAR DIAGNOSTICS MARKET BY APPLICATION 2012 - 2015, USD MILLION
TABLE 152 NIGERIA MOLECULAR DIAGNOSTICS MARKET BY APPLICATION 2016 - 2022, USD MILLION
TABLE 153 NIGERIA INFECTIOUS DISEASES MOLECULAR DIAGNOSTICS MARKET BY TYPE, 2012 - 2015, USD MILLION
TABLE 154 NIGERIA INFECTIOUS DISEASES MOLECULAR DIAGNOSTICS MARKET BY TYPE, 2016 - 2022, USD MILLION
TABLE 155 NIGERIA ONCOLOGY MOLECULAR DIAGNOSTICS MARKET BY TYPE, 2012 - 2015, USD MILLION
TABLE 156 NIGERIA ONCOLOGY MOLECULAR DIAGNOSTICS MARKET BY TYPE, 2016 - 2022, USD MILLION
TABLE 157 NIGERIA MOLECULAR DIAGNOSTICS MARKET BY END USER, 2012 - 2015, USD MILLION
TABLE 158 NIGERIA MOLECULAR DIAGNOSTICS MARKET BY END USER, 2016 - 2022, USD MILLION
TABLE 159 REST OF LAMEA MOLECULAR DIAGNOSTICS MARKET, 2012 - 2015, USD MILLION
TABLE 160 REST OF LAMEA MOLECULAR DIAGNOSTICS MARKET, 2016 - 2022, USD MILLION
TABLE 161 REST OF LAMEA MOLECULAR DIAGNOSTICS MARKET BY PRODUCT & SERVICES, 2012 - 2015, USD MILLION
TABLE 162 REST OF LAMEA MOLECULAR DIAGNOSTICS MARKET BY PRODUCT & SERVICES, 2016 - 2022, USD MILLION
TABLE 163 REST OF LAMEA MOLECULAR DIAGNOSTICS MARKET BY TECHNOLOGY, 2012 - 2015, USD MILLION
TABLE 164 REST OF LAMEA MOLECULAR DIAGNOSTICS MARKET BY TECHNOLOGY, 2016 - 2022, USD MILLION
TABLE 165 REST OF LAMEA MOLECULAR DIAGNOSTICS MARKET BY APPLICATION 2012 - 2015, USD MILLION
TABLE 166 REST OF LAMEA MOLECULAR DIAGNOSTICS MARKET BY APPLICATION 2016 - 2022, USD MILLION
TABLE 167 REST OF LAMEA INFECTIOUS DISEASES MOLECULAR DIAGNOSTICS MARKET BY TYPE, 2012 - 2015, USD MILLION
TABLE 168 REST OF LAMEA INFECTIOUS DISEASES MOLECULAR DIAGNOSTICS MARKET BY TYPE, 2016 - 2022, USD MILLION
TABLE 169 REST OF LAMEA ONCOLOGY MOLECULAR DIAGNOSTICS MARKET BY TYPE, 2012 - 2015, USD MILLION
TABLE 170 REST OF LAMEA ONCOLOGY MOLECULAR DIAGNOSTICS MARKET BY TYPE, 2016 - 2022, USD MILLION
TABLE 171 REST OF LAMEA MOLECULAR DIAGNOSTICS MARKET BY END USER, 2012 - 2015, USD MILLION
TABLE 172 REST OF LAMEA MOLECULAR DIAGNOSTICS MARKET BY END USER, 2016 - 2022, USD MILLION
TABLE 173 KEY INFORMATION – ABBOTT LABORATORIES.
TABLE 174 KEY INFORMATION – QUIAGEN N.V.
TABLE 175 KEY INFORMATION – ROCHE DIAGNOSTIC
TABLE 176 KEY INFORMATION – GRIFOLS
TABLE 177 KEY INFORMATION – SIEMENS HEALTHCARE (SIEMENS AG)
TABLE 178 KEY INFORMATION – BECTON DICKINSON AND COMPANY
TABLE 179 KEY INFORMATION – DANAHER CORPORATION
